Using a triple endpoint of death, nonfatal MI, or need for revascularization, the authors found that "event rates were higher in every aPTT strata compared with enoxaparin and statistically ...

This finding highlights the superior bioavailability of enoxaparin; in contrast, unfractionated heparin requires careful coagulation monitoring. Whether there is an optimal anti–factor Xa level ...

They had whole blood Hemonox clotting time and activated partial thromboplastin time (aPTT) measured at baseline and at 10 minutes after the intravenous administration of enoxaparin in patients ...

These findings, coupled with an assessment of ease of administration and cost compared to other drugs, leads researchers from Duke University Medical Center to recommend the drug enoxaparin ...

Enoxaparin was initiated 12 hours before surgery ... The study was designed and supervised by the Regulation of Coagulation in Orthopedic Surgery to Prevent Deep Venous Thrombosis and Pulmonary ...

The overall cumulative incidence rates of symptomatic VTEs were 15.1 and 6.4 percent for the observation and enoxaparin groups, respectively (hazard ratio, 0.40; 95 percent CI, 0.19 to 0.83; P = 0 ...

Addressing the pressing demand for rapid and inexpensive coagulation testing in cardiovascular ... between RBC wicked diffusion distance and enoxaparin concentration paves the way for machine ...

The only treatment-related adverse event (AEs) in any arm was one case of minimal bleeding reported in the enoxaparin arm ... inhibition of the intrinsic coagulation pathway, the company outlined ...

Inhibitors of coagulation factor Xa (fXa ... in blood loss resulting from ATIII-dependent anticoagulation by enoxaparin or fondaparinux. r-Antidote has the potential to be used as a universal ...

Among over 17,000 patients, the more selective enoxaparin protocol was associated with a reduction in wound hematomas compared with the original standard protocol (0.3% vs 0.7%; adjusted OR 0.38 ...